Wolverine Trading, LLC Abb Vie Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 12,516 shares of ABBV stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,516

Previous 156,363 92.0%

Holding current value

$2.27 Million

Previous $26.8 Million 90.79%

% of portfolio

0.0%

Previous 0.03%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $23.6 Million - $28.7 Million	-143,847 Reduced 92.0%	12,516 $2.47 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $958,769 - $1.12 Million	6,194 Added 4.12%	156,363 $26.8 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1.97 Million - $2.24 Million	12,303 Added 8.92%	150,169 $27.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $3.59 Million - $4.05 Million	26,119 Added 23.37%	137,866 $21.4 Million
Q3 2023 Nov 15, 2023	BUY	$133.59 - $154.65 $10.4 Million - $12 Million	77,855 Added 229.71%	111,747 $16.7 Million
Q2 2023 Aug 23, 2023	BUY	$132.51 - $164.9 $2.7 Million - $3.36 Million	20,390 Added 151.01%	33,892 $4.57 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $116 Million - $134 Million	-803,440 Reduced 98.35%	13,502 $2.13 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $112 Million - $134 Million	809,622 Added 11060.41%	816,942 $132 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $982,417 - $1.13 Million	7,320 New	7,320 $1.05 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $6.1 Million - $7.57 Million	-46,223 Reduced 48.13%	49,819 $8.16 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $5.4 Million - $6.83 Million	50,273 Added 109.84%	96,042 $13.1 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.44 Million - $1.63 Million	-13,505 Reduced 22.78%	45,769 $4.98 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $2.12 Million - $2.36 Million	20,116 Added 51.37%	59,274 $6.66 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $8.83 Million - $9.72 Million	-86,328 Reduced 68.79%	39,158 $4.18 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $5.54 Million - $7.48 Million	68,809 Added 121.41%	125,486 $13.2 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $2.07 Million - $2.43 Million	24,103 Added 73.99%	56,677 $4.93 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $188,781 - $252,617	2,573 Added 8.58%	32,574 $3.14 Million
Q1 2020 May 11, 2020	SELL	$64.5 - $97.79 $12 Million - $18.2 Million	-185,763 Reduced 86.1%	30,001 $2.26 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $10.1 Million - $12.7 Million	140,448 Added 186.48%	215,764 $19.1 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1.71 Million - $2.05 Million	27,104 Added 56.22%	75,316 $5.64 Million
Q2 2019 Aug 20, 2019	BUY	$65.7 - $83.98 $2.94 Million - $3.75 Million	44,684 Added 1266.55%	48,212 $3.51 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $3.24 Million - $3.81 Million	-41,978 Reduced 92.25%	3,528 $284,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $2.25 Million - $2.77 Million	28,847 Added 173.16%	45,506 $4.15 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $4.56 Million - $5.06 Million	-51,235 Reduced 75.46%	16,659 $1.58 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.46 Million - $1.96 Million	-15,896 Reduced 18.97%	67,894 $6.43 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $7.5 Million - $8.23 Million	83,790	83,790 $8.1 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $320B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Abb Vie Inc. Transaction History